CC
AGN

Claybrook Capital’s Allergan plc AGN Stock Holding History

Claybrook Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-700
Closed -$133K – 844
2018
Q3 		$133K Hold
700
– – 0.08% 86
2018
Q2 		$117K Hold
700
– – 0.07% 87
2018
Q1 		$118K Hold
700
– – 0.08% 83
2017
Q4 		$115K Buy
+700
New +$126K 0.08% 94

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Claybrook Capital's AGN Position: Q4 2018 in Review

Claybrook Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 700 shares — an estimated $133K sold.

Claybrook Capital first reported a position in AGN in Q4 2017 and held it in 4 quarters. The position peaked at $133K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Claybrook Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Claybrook Capital sold 700 Allergan plc shares in Q4 2018, an estimated $133K.
  • Claybrook Capital first reported a position in Allergan plc in Q4 2017 and held it in 4 quarters.
  • Claybrook Capital's Allergan plc position peaked at $133K in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Claybrook Capital's 13F filing for Q4 2018, filed 14 Feb 2019.